drugset / Trial / NCT02488980

An Evaluation of Weekly Tafenoquine

NCT02488980

RandomizedParallel-groupTriple-blindTreatment

Summary

This was a placebo controlled, randomised, double-blind, double-dummy study of the efficacy of weekly tafenoquine compared with weekly mefloquine or placebo in the chemosuppression of P. falciparum in Nyanza Province, western Kenya.

Timeline

Start
2000-05
Primary completion
2000-10
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mefloquine Unknown 250 mg
Subject Tafenoquine Small molecule 200 mg